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Abstract
Exosomes might have an unimproved potential to serve as effective delivery vehicles. How-
ever, when exosomes are developed for therapeutic applications, a method to enhance
their delivery is important. This study aimed to evaluate wheather calcium chloride (CaCl2)
or other chloride compounds could enhance exosome delivery to various cells without caus-
ing toxicity. Exosomes were purified from human serum by using the ExoQuick exosome
precipitation kit. Isolated exosomes were mixed with CaCl2 at concentrations ranging from
100 μM to 1 mM, and then washed using Amicon filter for treating the cells. The delivery effi-
ciency of exosomes and the viability of the cells [HEK 293 (human kidney cells) and H9C2
(rat cardiomyocytes)] were evaluated. Cellular uptake of exosomes was observed using a
confocal microscope based on PKH26 labeling of exosomes. CaCl2 increased the delivery
of exosomes in a dose- and treatment time-dependent manner. In HEK 293 cells, a CaCl2
concentration of 400 μM and exposure time of 12 h increased the delivery of exosomes by
>20 times compared with controls. In H9C2 cells, a CaCl2 concentration of 400 μM and
exposure time of >24 h increased the delivery of exosomes by >400 times compared with
controls. The viability of both cell lines was maintained up to a CaCl2 concentration of 1 mM.
However, cobalt chloride, cupric chloride, and magnesium chloride did not change the deliv-
ery of exosomes in both cell lines. These results suggest that the use of CaCl2 treatment
might be a useful method for enhancing the delivery of exosomes.
Introduction
Exosomes are 40–200nm vesicles secreted by many types of cells [1]. They exist in cell culture
medium and in numerous body fluids including plasma and serum [2]. The biogenesis of exo-
somes involves the fusion of multivesicular bodies enclosing pools of endosomal vesicles with
the cell plasma membrane and the subsequent release of the vesicles into intercellular space
[3]. These vesicles are known to carry a variety of signaling molecules, including nucleic acids,
predominantly mRNA and microRNA, functional proteins, and lipids [4]. Owing to their out-
standing cell-to-cell communication characteristic, numerous studies have investigated the
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role of exosomes in physiological and pathophysiological processes, including immune modu-
lation [5,6], tumor metastasis [7], and neurodegenerative diseases [8,9].
Many studies have suggested that exosomes can be ideal candidates for use as carriers for
drug delivery [10,11]. Exosomes have been used as delivery vehicles of small nucleic acids such
as micro-RNAs and small interfering RNAs or low-molecular-weight medicines [12,13]. Exo-
some-liposome hybrid nanoparticles can deliver the CRISPR-Cas9 system in mesenchymal
stem cells, and thus can be promising tools in in vivo gene manipulation [14]. The organ-spe-
cific delivery of exosomes was improved by expressing target peptides with Lamp2 on the sur-
face of exosomes [12,15–17]. Pseudotyping exosomes have been suggested as vehicles for the
enhanced delivery of protein reporters and protein therapeutics to target cells [18]. However, a
simpler method for enhancing the delivery efficacy of exosomes is needed [19].
To date, calcium chloride (CaCl2)-associated transfection methods have been widely used
to introduce DNA into mammalian cells, with relatively low cost and low toxicity [20]. How-
ever, whether CaCl2 can increase the delivery efficiency of exosomes to the target cells has not
been evaluated. In a recent study, CaCl2 and subsequent heat shock-mediated miR-15a-loaded
exosomes showed higher delivery of miR-15a to target cells than miR-15a-electroporated exo-
some [21]. Taken together, we hypothesized that CaCl2 or other chloride compounds can
affect the delivery efficacy of exosomes into target cells.
Thus, we aimed to investigate whether exosomes mixed with CaCl2 can show improved
delivery to cells compared with normal exosomes, thus providing an effective method for drug
delivery in the future.
Materials and methods
Exosome purification and labeling
Human peripheral blood samples from non-atrial fibrillation patients were obtained at Yonsei
University Health System (Seoul, Korea). The study protocol conformed to the principles out-
lined in Declaration of Helsinki, and was approved by the local ethics committee (YUMC 4-
2011-0872). Informed consent was obtained from all patients. The name of ethics committee is
as follows: Severance Hospital.
Exosomes were purified using the ExoQuick exosome precipitation kit (SBI System Biosci-
ence, Mountain View, CA, USA), according to manufacturer’s instructions. A 250 μL volume
of human serum was mixed with 63 μL ExoQuick solution and incubated overnight at 4˚C.
After centrifugation (1500g for 30 min), the supernatant was discarded and tubes were centri-
fuged again (1500g for 5 min). All traces of fluid were aspirated, then pellets were resuspended
in 200 μL phosphate-buffered saline (PBS) [22].
After exosome treatment to cells, the uptake of exosomes by cultured HEK 293 cells
(human kidney cells) and H9C2 cells (rat cardiomyocytes) was assessed using a confocal
microscope (LSM710; Carl Zeiss GmbH, Jena, Germany). For this evaluation, purified exo-
somes were labeled using PKH26 dye (Sigma, Germany) according to the manufacturer’s
instructions, as described previously [23]. Briefly, exosomes were suspended in 1 mL diluent C
containing 5 μM PKH26 and incubated for 5 min. The labeling action was stopped by incubat-
ing for 1 min with an equal volume of 1% bovine serum albumin (Bovogen, Melbourne, Aus-
tralia). The exosomes were washed twice with Amicon ultrafilter (10 KDa cut-off, Millipore,
MA, USA) with cold PBS. Thereafter, the exosomes were resuspended in 200 μL PBS.
Mixture of exosomes and CaCl2
To deliver exosomes efficiently to cells, a modified method of CaCl2 transfection was devel-
oped. PKH26-labeled exosomes (50 μg in PBS) were mixed with CaCl2 solution (0.2 M stock).
Enhancing exosome uptake by calcium chloride treatment
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The final volume was adjusted to 150 μL using sterile PBS. The mixture was incubated at 37˚C
in a shaker for 10 min at 25 rpm, and then the tube was immediately placed on ice. The Exo-
Quick reagent (30 μL) was added, and the mixture was placed on ice for 30 min. The sample
was centrifuged for 3 min at 13,000–14,000 rpm in a microfuge. The supernatant was removed,
and the mixture pellet was resuspended in 1 mL PBS. The pellet was washed using Amicon
Ultra tubes with cold PBS. Thereafter, the exosomes were resuspended in 200 μL PBS.
Western blot analysis
Western blot analysis was performed as we described previously [16]. Briefly, ultracentrifuged
exosomal pellets were lysed with radioimmunoprecipitation buffer (ATTO, NY, USA) con-
taining a protease inhibitor cocktail (ATTO). The total amount of protein was determined
using a 660-nm protein assay (Pierce, MA, USA), and equal amounts (20 μg) of exosomal pro-
teins were resolved using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred to polyvinylidene difluoride membranes. The blots were probed overnight at 4˚C
with anti-Lamp2 (SC-18822; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-CD81
(SC-166029, Santa Cruz Biotechnology), or anti-Alix (SC-99010, Santa Cruz Biotechnology),
as indicated. The membranes were then exposed to horseradish peroxidase-conjugated mouse
or rabbit anti-mouse secondary antibodies (Santa Cruz Biotechnology), and the results were
visualized using chemiluminescence (Advansta, Menlo Park, CA, USA).
Transmission electron microscopy
A Formvar-carbon-coated electron microscope grid was placed with the formvar side down
on top of an exosome drop for approximately 1 min. The grid was removed, blotted with filter
paper, and placed onto a drop of 2% uranyl acetate for 15 s. The excess uranyl acetate was
removed, and the electron microscope grid was examined and photographed for transmission
electron microscopy (TEM). All thin sections were observed under a transmission electron
microscope (JEM-1011; JEOL, Tokyo, Japan) at an acceleration voltage of 80 kV. Images were
captured with a side-mounted Camera-Megaview III (Soft Imaging System, Mu¨nster, Ger-
many) [24].
Nanoparticle tracking analysis
The number of nanoparticles in serum-derived exosomes was assessed using the Nanosight
LM10-HS nanoparticle characterization system (Nanosight Ltd., Amesbury, UK). Three
recordings were performed for each sample. The Nanosight Tracking Analysis 3.2 software
was then used to analyze the video, and to determine the particle concentration and the size
distribution of the particles. Three videos of 10-s duration were recorded for each sample.
Cell culture
HEK 293 cells and H9C2 cells were cultivated as we described previously [16]. Briefly, HEK
293 cells (Korean Cell Line Bank, Seoul, Korea) and H9C2 cells (American Type Culture Col-
lection, Manassas, VA, USA) were maintained in Dulbecco’s modified Eagle’s medium (Wel-
gene, Daegu, Korea) containing 10% fetal bovine serum (Young In Frontier, Seoul, Korea) and
1% penicillin-streptomycin (Gibco, NY, USA). Cells were cultured in a humidified incubator
at 37˚C with 5% CO2.
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Immunocytochemistry and confocal microscopy
Immunocytochemistry and confocal microscopy were executed as we described previously
[16]. After treating HEK 293 and H9C2 cells with or without exosomes for 24 h, the cells were
fixed with 4% paraformaldehyde for 60 min at room temperature and washed with PBS. Cell
nuclei were stained with 406-diamidino-2-phenylindole (Santa Cruz Biotechnology). Fluores-
cence images were obtained using a Zeiss LSM710 confocal microscope with 2 excitation filters
(405 and 543 nm). The data were recorded as serial optical sections, each consisting of
1024 × 1024 pixels, overlaid to distinguish between the separate emission channels, and saved
as TIFF (tagged image file format) files. Quantification was performed using Image J program.
PKH26 expression and DAPI expression were measured respectively using the RGB function
of histogram. The same slide was averaged by taking three different parts, and the number of
samples was three.
Cell proliferation assay
The cytotoxic potential of exosomes was assessed using an MTS [3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay (Promega, Madison,
WI, USA). HEK 293 cells were treated with exosomes in triplicate in a 96-well plate. Cell sur-
vival was determined using an enzyme-linked immunosorbent assay plate reader (Molecular
Devices, Menlo Park, CA, USA).
Mouse and NIRF imaging
Male C57BL/6 mice (25 g) were purchased from Orient Bio (Seoul, Korea). All animal experi-
ments were approved by the Institutional Animal Care and Use Committee of Yonsei Univer-
sity College of Medicine (Seoul, Korea), and were conducted in accordance with the National
Institutes of Health Guidelines for the Care and Use of Laboratory Animals. We injected
150 μg of PKH26 labeled exosomes per animal. After 24 h, the heart, liver, and spleen of each
mouse were harvested and IVIS Spectrum imaging system (PerkinElmer, Waltham, MA,
USA) was employed to capture Near-infrared fluorescence (NIRF) images. PKH26-related
fluorescence signals were discriminated from the auto-fluorescence signals using Living Image
software (PerkinElmer).
Statistical analysis
Data analyses were performed with Student’s t-test between two groups. A p-value of<0.05
was considered statistically significant. All statistical analyses were conducted with SPSS ver-
sion 23.0 statistical package (SPSS Inc., Chicago, IL, USA).
Results
Isolation and characterization of serum exosomes
The protocol of preparing the mixture of exosomes and CaCl2 is shown in Fig 1A. CaCl2-asso-
ciated transfection methods are widely used for introducing DNA into mammalian cells [20].
We used a modified protocol in which incubation at 37˚C in a shaker was performed to
increase exosome delivery to cells. Exosomes were isolated from peripheral blood by using the
ExoQuick reagent, as described in Materials and Methods. The profiles of serum-derived exo-
somes were characterized using nanoparticle tracking analysis, TEM, and western blotting.
According to the Nanosight instrument, the mean particle diameter was 136.6 nm, and mean
concentration was 8.59×107 particles/ml (Fig 1B). And structurally intact exosomes were
detected by TEM analysis (Fig 1C). There was no significant difference in the size and
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concentration of exosomes before and after addition of CaCl2 when TEM and NTA were com-
pared (S1 Fig). When cell lysate and exosome were examined by western blot analysis, the exo-
somes were positive for exosomal markers including Alix, CD81, and Lamp2 (Fig 1D). Taken
together, the exosomes were successfully purified.
CaCl2 dose-dependent delivery of exosomes to HEK 293 and H9C2 cells
To identify whether CaCl2 treatment improves delivery of exosomes, we added several concen-
trations of CaCl2 to exosomes and these mixtures were incubated at 37˚C in a shaker. The mix-
ture of exosomes and CaCl2 was used to treat the HEK 293 and H9C2 cells, which were then
incubated for 24 h. The most commonly used method for monitoring exosome uptake is to
stain exosomal membranes with fluorescent lipid membrane dyes such as PKH26 [25], PKH67
[26], and DiI [27]. In this study, PKH26 was used to label the exosomes and to monitor the
uptake of labeled exosomes by cells. The uptake of labeled exosomes by cells was confirmed
using a confocal microscope (Fig 2A).
Fig 1. Characterization of exosomes. (A) Study protocol. (B) Nanoparticle tracking analysis of exosomes showing the number and size distribution of particles. (C)
Representative electron microscopic image of the exosomes (scale bar, 40 nm). (D) Western blot analysis of isolated exosomes and cell lysate.
https://doi.org/10.1371/journal.pone.0220036.g001
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In HEK 293 cells, the delivery of exosomes was dose-dependently increased. At a CaCl2
concentration of 400 μM (P< 0.001), the delivery of exosomes increased the most, and then
reached a plateau. In H9C2 cells, the delivery of exosomes was significantly increased over 400
times (P = 0.003) at a CaCl2 concentration of 200 μM, After peaking at 400 μM, it decreased at
higher concentrations (P < 0.001).
In order for exosomes to be used as therapeutic application, there should be no damage to
the cells. Thus, we checked cell viability after exosomes incubation. Cell viability was main-
tained up to a CaCl2 concentration of 1 mM in both cells (Fig 2B and 2C). As a result, we
found that the CaCl2 treatment improved the delivery of exosomes to cells without toxicity.
Fig 2. Delivery efficiency of exosomes with CaCl2 in a dose-dependent manner. (A) Typical example of delivery of exosomes to HEK 293 cells (left panels) and H9C2
cells (right panels). (B) and (C) Delivery efficiency and cell viability of exosomes labeled with PKH26 (red) at different concentrations of CaCl2 in HEK 293 (B) and
H9C2 (C) cells. Fluorescent microscopic images (left panels), and fluorescence intensity and cell viability (right panels). The data are presented as the mean ± s.e.m.
�P< 0.01.
https://doi.org/10.1371/journal.pone.0220036.g002
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Optimal time for exosome uptake by cells
Because 400 μM was the CaCl2 concentration with the maximum delivery of exosomes, we
evaluated the cellular uptake of exosomes at different durations of exposure to these CaCl2-
treated exosomes. In HEK 293 cells, the cellular uptake of exosomes increased as the incuba-
tion time increased, with saturation at around 12 h and a decrease after 24 h (Fig 3A,
P< 0.0001). In H9C2 cells, the uptake increased as the incubation time increased, with satura-
tion at around 24 h and a decrease after 48 h (Fig 3B, P < 0.0001). Taken together, we found
the most efficient concentration of CaCl2 and the appropriate treatment time.
CaCl2 is more effective than other chloride compounds
Next, we assessed whether the cellular uptake of exosomes will be increased by other chlo-
ride compounds. Cobalt chloride (CoCl2), magnesium chloride (MgCl2) and cupric chlo-
ride (CuCl2) were treated exosome at a concentration of 400μM for 24 hours. Exosome
delivery and cell viability were measured by the above method. In HEK 293 cells, the cellular
delivery of exosomes was not significantly improved by CoCl2 or MgCl2, but was rather
decreased by CuCl2 (Fig 4A). In H9C2 cells, the cellular delivery of exosomes was improved
by CoCl2 (P = 0.017) and MgCl2 (P = 0.004), but not by CuCl2 (Fig 4B). Moreover, the cell
viability was significantly decreased by MgCl2 in both cell lines. These results show that
CaCl2 significantly enhances intracellular delivery of exosomes compared to other chloride
compounds.
Fig 3. Delivery efficiency of exosomes with CaCl2 in a time-dependent manner. (A) and (B) Delivery efficiency of exosomes labeled with PKH26 (red) at different
time exposures to CaCl2-treated exosomes in HEK 293 (A) and H9C2 (B) cells. Fluorescent microscopic images (upper panels) and fluorescence intensity (lower panels).
�P< 0.01.
https://doi.org/10.1371/journal.pone.0220036.g003
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In vivo delivery of CaCl2-treated exosomes
We also performed in vivo experiments to support the claim that CaCl2 enhances the delivery
of exosomes. Exosomes were injected via tail vein in mice and sacrificed 24 hours later. The
level of PKH26 was measured using In Vivo Imaging System (IVIS) of organs. We confirmed
Fig 4. Delivery efficiency of exosomes with chloride compounds. (A, C) Delivery efficiency and (B, D) cell viability of exosomes labeled with PKH26 (red) added with
different chloride compounds in HEK 293 (A,B) and H9C2 (C,D) cells. Fluorescent microscopic images (upper panels), and fluorescence intensity and cell viability
(lower panels). �P< 0.01.
https://doi.org/10.1371/journal.pone.0220036.g004
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PLOS ONE | https://doi.org/10.1371/journal.pone.0220036 July 22, 2019 8 / 12
that CaCl2-treated exosomes significantly increased the delivery in heart, lung, kidney, and
spleen (S3 Fig). Based on these results, we suggest that CaCl2-treated exosomes allow higher
delivery than normal exosomes in vivo.
Discussion
In this study, we attempted to enhance the delivery efficiency of exosomes by using CaCl2,
which is commonly used for transfection of DNA into mammalian cells. Exosomes incubated
with CaCl2 increased delivery efficiency in a dose-dependent manner in HEK 293 and H9C2
cells. The optimum duration of treatment with exosomes added with CaCl2 was 12 h for HEK
293 cells and 24 h for H9C2 cells. Finally, it was confirmed that CaCl2 significantly increased
the intracellular uptake of exosomes when compared with other chloride compounds at the
same concentration. On the basis of these results, we suggest that adding CaCl2 to exosomes
for treating the cells is an efficient method of increasing the delivery of exosomes.
Exosomes are vesicles of endocytic origin released by many cells [28]. They are crucial in
distant cell-cell communication because they can enter the circulatory system when they are
secreted and can pass through additional biological barriers [29]. R. Liu et al. recent accumu-
lated evidence suggests that these nano-sized vesicles can deliver various RNAs into cells from
the natural pathway, to deliver genetic material in organisms [30]. As exosomes are promising
for use as vectors in clinical applications owing to their strong biocompatibility, enhancement
of exosome delivery is an important research topic [31]. One of the limitations of exosomes is
the requirement for high capacity production for clinical use [19,32]. Our findings provide a
solution to this limitation.
In the standard method for transforming of Escherichia coli with external DNA, cells are
known to be suitable for DNA uptake by incubating in ice-cold 100 mM CaCl2 [33]. CaCl2
assists the interactions between DNA molecules and the cell surface and helps endocytosis of
the DNA molecules [34]. We modified this protocol to increase the uptake of exosomes into
cells. Also, calcium influx induces endocytosis and exocytosis, and is known to trigger vesicle
fusion [35–37]. Therefore, we anticipate that the addition of CaCl2 increases the efficiency of
exosome delivery. However, more research is needed to confirm these mechanisms. In our
study, up to 1 mM CaCl2 was used, but no cytotoxicity was observed. Moreover, CaCl2 is a
common compound used in various research institutes. In this experiment, a low CaCl2 con-
centration was used, thus providing the advantages of low cost and high accessibility. We also
compared CaCl2 with other chloride compounds. Our results showed that CaCl2 was the only
common enhancer of exosome delivery between HEK 293 and H9C2 cells. Our findings pro-
vide useful technological insights for the development of exosome-mediated drug delivery.
Supporting information
S1 Fig. Characterization of CaCl2-Exo. (A) Representative electron microscopic image of
CaCl2-Exo (scale bar, 40 nm). (B) Size distribution of CaCl2-Exo measured from TEM images.
(C) Nanoparticle tracking analysis of CaCl2-Exo showing the concentration of particles.
(TIF)
S2 Fig. Un-cropped Western blots from main Fig 1.
(TIF)
S3 Fig. In vivo delivery of exosomes and CaCl2-Exo. (A) Representative NIRF images (over-
laid with photograph) of mice organs which received administration of PBS, PKH26-labeled
exosomes, or CaCl2-Exo. (B) Quantitation of fluorescence intensity in the lesion region.
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(TIF)
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